Aurobindo Pharma (India) Price History
AUROPHARMA | 1,224 6.70 0.55% |
Below is the normalized historical share price chart for Aurobindo Pharma Limited extending back to October 19, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aurobindo Pharma stands at 1,224, as last reported on the 25th of November, with the highest price reaching 1,231 and the lowest price hitting 1,216 during the day.
If you're considering investing in Aurobindo Stock, it is important to understand the factors that can impact its price. Aurobindo Pharma secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3% return per unit of risk over the last 3 months. Aurobindo Pharma Limited exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aurobindo Pharma's Risk Adjusted Performance of (0.21), standard deviation of 1.22, and Mean Deviation of 0.9673 to double-check the risk estimate we provide.
At present, Aurobindo Pharma's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 473.3 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 649.9 M. . Aurobindo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.3 K | 50 Day MA 1.4 K | Beta 0.593 |
Aurobindo |
Sharpe Ratio = -0.301
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AUROPHARMA |
Estimated Market Risk
1.22 actual daily | 10 90% of assets are more volatile |
Expected Return
-0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.3 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aurobindo Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurobindo Pharma by adding Aurobindo Pharma to a well-diversified portfolio.
Price Book 2.3017 | Enterprise Value Ebitda 10.3937 | Price Sales 2.3447 | Shares Float 290.9 M | Dividend Share 1.5 |
Aurobindo Pharma Stock Price History Chart
There are several ways to analyze Aurobindo Stock price data. The simplest method is using a basic Aurobindo candlestick price chart, which shows Aurobindo Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 30, 2024 | 1568.05 |
Lowest Price | November 21, 2024 | 1217.0 |
Aurobindo Pharma November 25, 2024 Stock Price Synopsis
Various analyses of Aurobindo Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aurobindo Stock. It can be used to describe the percentage change in the price of Aurobindo Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aurobindo Stock.Aurobindo Pharma Price Daily Balance Of Power | 0.42 | |
Aurobindo Pharma Price Action Indicator | 3.55 | |
Aurobindo Pharma Price Rate Of Daily Change | 1.01 |
Aurobindo Pharma November 25, 2024 Stock Price Analysis
Aurobindo Stock Price History Data
The price series of Aurobindo Pharma for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 351.05 with a coefficient of variation of 6.61. The prices are distributed with arithmetic mean of 1458.11. The median price for the last 90 days is 1480.95. The company had 2:1 stock split on 20th of July 2015. Aurobindo Pharma issued dividends on 2024-02-20.Open | High | Low | Close | Volume | ||
11/25/2024 | 1,220 | 1,231 | 1,216 | 1,224 | ||
11/22/2024 | 1,220 | 1,231 | 1,216 | 1,224 | 494,219 | |
11/21/2024 | 1,254 | 1,254 | 1,216 | 1,217 | 397,963 | |
11/19/2024 | 1,239 | 1,267 | 1,232 | 1,246 | 879,809 | |
11/18/2024 | 1,245 | 1,255 | 1,232 | 1,237 | 1,362,480 | |
11/14/2024 | 1,250 | 1,272 | 1,242 | 1,251 | 832,369 | |
11/13/2024 | 1,274 | 1,274 | 1,241 | 1,258 | 803,439 | |
11/12/2024 | 1,289 | 1,302 | 1,258 | 1,270 | 1,007,201 | |
11/11/2024 | 1,331 | 1,361 | 1,257 | 1,286 | 3,249,749 | |
11/08/2024 | 1,355 | 1,358 | 1,320 | 1,325 | 2,540,891 | |
11/07/2024 | 1,396 | 1,399 | 1,346 | 1,350 | 870,441 | |
11/06/2024 | 1,400 | 1,413 | 1,392 | 1,394 | 1,415,065 | |
11/05/2024 | 1,407 | 1,417 | 1,361 | 1,395 | 999,960 | |
11/04/2024 | 1,396 | 1,411 | 1,382 | 1,405 | 872,401 | |
11/01/2024 | 1,407 | 1,410 | 1,394 | 1,394 | 39,844 | |
10/31/2024 | 1,406 | 1,419 | 1,389 | 1,395 | 766,784 | |
10/30/2024 | 1,406 | 1,420 | 1,385 | 1,405 | 535,058 | |
10/29/2024 | 1,442 | 1,442 | 1,398 | 1,405 | 569,909 | |
10/28/2024 | 1,422 | 1,442 | 1,406 | 1,435 | 1,258,823 | |
10/25/2024 | 1,441 | 1,457 | 1,415 | 1,426 | 470,066 | |
10/24/2024 | 1,432 | 1,452 | 1,429 | 1,445 | 451,113 | |
10/23/2024 | 1,446 | 1,466 | 1,429 | 1,430 | 623,144 | |
10/22/2024 | 1,460 | 1,482 | 1,441 | 1,446 | 661,461 | |
10/21/2024 | 1,473 | 1,500 | 1,449 | 1,458 | 874,694 | |
10/18/2024 | 1,460 | 1,482 | 1,450 | 1,470 | 437,609 | |
10/17/2024 | 1,482 | 1,487 | 1,462 | 1,464 | 736,438 | |
10/16/2024 | 1,480 | 1,487 | 1,464 | 1,481 | 606,484 | |
10/15/2024 | 1,497 | 1,499 | 1,467 | 1,480 | 574,286 | |
10/14/2024 | 1,496 | 1,503 | 1,469 | 1,490 | 741,192 | |
10/11/2024 | 1,477 | 1,499 | 1,474 | 1,492 | 620,340 | |
10/10/2024 | 1,512 | 1,516 | 1,456 | 1,470 | 1,145,802 | |
10/09/2024 | 1,492 | 1,520 | 1,483 | 1,506 | 791,236 | |
10/08/2024 | 1,453 | 1,496 | 1,440 | 1,489 | 661,516 | |
10/07/2024 | 1,467 | 1,489 | 1,442 | 1,460 | 1,218,725 | |
10/04/2024 | 1,458 | 1,490 | 1,442 | 1,460 | 923,928 | |
10/03/2024 | 1,438 | 1,463 | 1,425 | 1,455 | 1,525,846 | |
10/01/2024 | 1,455 | 1,462 | 1,407 | 1,442 | 2,603,178 | |
09/30/2024 | 1,512 | 1,519 | 1,444 | 1,465 | 1,857,748 | |
09/27/2024 | 1,505 | 1,521 | 1,490 | 1,508 | 704,353 | |
09/26/2024 | 1,530 | 1,530 | 1,494 | 1,508 | 853,880 | |
09/25/2024 | 1,507 | 1,531 | 1,498 | 1,528 | 1,026,040 | |
09/24/2024 | 1,487 | 1,508 | 1,472 | 1,508 | 1,153,620 | |
09/23/2024 | 1,498 | 1,510 | 1,470 | 1,481 | 2,358,329 | |
09/20/2024 | 1,538 | 1,541 | 1,483 | 1,497 | 2,007,987 | |
09/19/2024 | 1,550 | 1,560 | 1,511 | 1,528 | 692,586 | |
09/18/2024 | 1,552 | 1,560 | 1,518 | 1,536 | 581,463 | |
09/17/2024 | 1,564 | 1,568 | 1,549 | 1,550 | 584,857 | |
09/16/2024 | 1,575 | 1,584 | 1,551 | 1,567 | 1,277,762 | |
09/13/2024 | 1,565 | 1,592 | 1,555 | 1,565 | 1,185,312 | |
09/12/2024 | 1,522 | 1,578 | 1,522 | 1,564 | 4,067,763 | |
09/11/2024 | 1,534 | 1,546 | 1,502 | 1,520 | 979,903 | |
09/10/2024 | 1,528 | 1,535 | 1,515 | 1,517 | 877,176 | |
09/09/2024 | 1,537 | 1,540 | 1,513 | 1,520 | 841,713 | |
09/06/2024 | 1,534 | 1,547 | 1,516 | 1,538 | 1,043,914 | |
09/05/2024 | 1,542 | 1,559 | 1,530 | 1,534 | 1,023,539 | |
09/04/2024 | 1,528 | 1,556 | 1,528 | 1,550 | 1,069,656 | |
09/03/2024 | 1,553 | 1,570 | 1,546 | 1,547 | 1,033,542 | |
09/02/2024 | 1,581 | 1,584 | 1,549 | 1,550 | 728,911 | |
08/30/2024 | 1,560 | 1,581 | 1,551 | 1,568 | 1,757,837 | |
08/29/2024 | 1,556 | 1,575 | 1,555 | 1,561 | 573,393 | |
08/28/2024 | 1,552 | 1,578 | 1,545 | 1,563 | 999,085 |
About Aurobindo Pharma Stock history
Aurobindo Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aurobindo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aurobindo Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aurobindo Pharma stock prices may prove useful in developing a viable investing in Aurobindo Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 673.8 M | 649.9 M | |
Net Income Applicable To Common Shares | 22.2 B | 27.1 B |
Aurobindo Pharma Quarterly Net Working Capital |
|
Aurobindo Pharma Stock Technical Analysis
Aurobindo Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Aurobindo Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aurobindo Pharma's price direction in advance. Along with the technical and fundamental analysis of Aurobindo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aurobindo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.21) | |||
Jensen Alpha | (0.37) | |||
Total Risk Alpha | (0.53) | |||
Treynor Ratio | (1.34) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Aurobindo Stock analysis
When running Aurobindo Pharma's price analysis, check to measure Aurobindo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurobindo Pharma is operating at the current time. Most of Aurobindo Pharma's value examination focuses on studying past and present price action to predict the probability of Aurobindo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurobindo Pharma's price. Additionally, you may evaluate how the addition of Aurobindo Pharma to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |